Department of Otolaryngology, Head and Neck Surgery, Flinders Medical Centre, Adelaide 5025, Australia.
Flinders Health and Medical Research Institute, College of Medicine and Public Heath, Flinders University, Adelaide 5025, Australia.
Medicina (Kaunas). 2021 May 12;57(5):480. doi: 10.3390/medicina57050480.
: The objective of this study was to assess the T-14 outcomes of the Bizact device for tonsillectomy in a pediatric population. : A case series chart review was undertaken at a public tertiary teaching hospital and private otolaryngology practice, with data collected from pediatric patients who underwent a Bizact tonsillectomy between July 2016 and October 2019 for any indication, whose parents consented to completing the T-14 questionnaire providing a parental perspective of the child's quality of life. Primary outcomes were T-14 scores recorded preoperatively and 6 weeks post-operatively. Secondary outcome measures were postoperative complications, including hemorrhage and readmission. 146 patients were identified. There was a significant improvement in T-14 scores from a median of 24 (Interquartile range (IQR) 18-33) prior to surgery to 2 (IQR 0-4) at 6 weeks postoperatively ( < 0.001). The post-tonsillectomy hemorrhage rate was 6.1% (9/146 participants). : Pediatric Bizact tonsillectomy is effective in treating common indications for pediatric tonsillectomy, reflected by improved parent-reported health-related quality of life T-14 scores postoperatively.
本研究旨在评估 Bizact 装置在儿科人群中行扁桃体切除术的 T-14 结局。在一家公立三级教学医院和私人耳鼻喉科诊所进行了病例系列图表回顾,收集了 2016 年 7 月至 2019 年 10 月期间因任何适应症接受 Bizact 扁桃体切除术的儿科患者的数据,其父母同意完成 T-14 问卷,提供患儿生活质量的家长观点。主要结局指标是术前和术后 6 周记录的 T-14 评分。次要结局指标是术后并发症,包括出血和再入院。共确定了 146 例患者。T-14 评分从术前中位数 24(四分位距 (IQR) 18-33)显著改善至术后 6 周的 2(IQR 0-4)(<0.001)。扁桃体切除术后出血率为 6.1%(9/146 例患者)。儿科 Bizact 扁桃体切除术有效治疗儿科扁桃体切除术的常见适应症,反映为术后家长报告的健康相关生活质量 T-14 评分改善。